Pangenomic Health Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NARA.CN research report →
Companywww.pangenomic.com
Pangenomic Health Inc. , a precision health company, develops a self-care digital platform to deliver personalized and evidence-based information about natural treatments to support mental health. It develops the Nara App, a mobile app that provides consumers with a knowledge base tailored to an individual's unique user profile; and the PlantGx Platform, a digital therapeutics clinic platform that provides health practitioners with access to user health data enabled from the Nara App by the patient and to receive patient referrals.
- CEO
- Maryam Marissen
- IPO
- 2022
- Employees
- 5
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $5.48M
- P/E
- -2.92
- P/S
- 0.00
- P/B
- -4.58
- EV/EBITDA
- -1.65
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 167.57%
- ROIC
- 173.17%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-3,431,478 · -90130.82%
- EPS
- $-0.19 · 76.83%
- Op Income
- $-3,421,451
- FCF YoY
- -3130.07%
Performance & Tape
- 52W High
- $2.57
- 52W Low
- $0.18
- 50D MA
- $0.44
- 200D MA
- $0.97
- Beta
- -0.80
- Avg Volume
- 2.42K
Get TickerSpark's AI analysis on NARA.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NARA.CN Coverage
We haven't published any research on NARA.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NARA.CN Report →